Liposarcoma
📧 Sign up to get email alerts when something new happens for Liposarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery [Phase 1]
Phase 1 clinical trial update assessing eribulin in combination with radiation therapy for patients with surgically resectable retroperitone…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors [Phase 1]
Phase 1 trial evaluating IL-15 armored glypican-3–specific CAR-T cells for solid tumors, including hepatocellular carcinoma and several pedi…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors [Phase 1]
This is an update on a Phase 1 trial of interleukin-15 armored GPC3-specific CAR-T cells for pediatric solid tumors, with results posted and…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Brightline-4: A Study to Test How Well Brigimadlin is Tolerated by People With a Type of Cancer Called Dedifferentiated Liposarcoma [Phase 3]
Phase 3 Brightline-4 trial evaluating brigimadlin tolerability in patients with dedifferentiated liposarcoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-04Clinical Trial Update: Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors [Phase 1]
Phase 1 trial evaluating cytokine-armored GPC3-targeted CAR-T cells in adults with solid tumors, including hepatocellular carcinoma; the stu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas [Phase 2]
A Phase II study evaluating the combination of eribulin and pembrolizumab in soft tissue sarcomas has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma [Phase 1, Phase 2]
Phase 1/2 study evaluating lenvatinib and eribulin in advanced soft tissue sarcoma has completed with posted results. The study includes lei…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas [Phase 2]
Phase 2 clinical trial of sitravatinib in advanced liposarcoma and other soft tissue sarcomas has completed and results have been posted. Th…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma [Phase 2]
Phase 2 clinical trial update for ATX-101 in advanced dedifferentiated liposarcoma and leiomyosarcoma has been terminated with results poste…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating doxorubicin with upfront dexrazoxane for advanced or metastatic soft tissue sarcoma has completed enrollment with r…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes [Phase 2]
Phase 2 trial evaluating oral regorafenib across selected sarcoma subtypes has completed enrollment with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents [Phase 1, Phase 2]
Phase 1/2 trial evaluating OR2805, a anti-CD163 monoclonal antibody, alone and with anticancer agents for solid tumors, with unspecified sta…
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery [Phase 1, Phase 2]
Clinical trial evaluating avelumab plus trabectedin in metastatic or unresectable liposarcoma and leiomyosarcoma; the study has terminated w…
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma [Phase 2]
Phase 2 trial update on trabectedin for liposarcoma and leiomyosarcoma completed.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Assessment of Helical Tomotherapy Radiotherapy (54 Gy) Followed by Surgery in Retro-peritoneal Liposarcoma [NA]
This completed clinical trial evaluated 54 Gy helical Tomotherapy radiotherapy followed by surgery for liposarcoma, with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas [Phase 2]
Phase 2 trial evaluating pazopanib hydrochloride combined with topotecan hydrochloride in adults with metastatic or recurrent soft tissue an…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial [Phase 2]
Phase II trial evaluating pazopanib for advanced or metastatic liposarcoma with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery [Phase 2]
A Phase 2 trial evaluating nivolumab with or without ipilimumab in metastatic or unresectable sarcoma shows results from a completed study.
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) [Phase 2]
Phase 2 trial evaluating CMB305 with atezolizumab versus atezolizumab alone in various sarcomas has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-27Clinical Trial Update: Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery [Phase 2]
Phase 2 study of efatutazone dihydrochloride in patients with previously treated myxoid liposarcoma that cannot be removed surgically has co…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma [Phase 2]
Open-label Phase 2 study of IMC-A12 (cixutumumab) in advanced sarcomas. Results were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma [Phase 3]
This clinical trial update notes the completion of a Phase 3 study evaluating trabectedin (YONDELIS) in patients with locally advanced or me…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma [Phase 2]
Phase 2 trial results of palbociclib in patients with advanced or metastatic liposarcoma were posted, detailing outcomes from the study.
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of ribociclib in patients with advanced liposarcoma, including well-differentiated…
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Bevacizumab and Radiation Therapy for Sarcomas [Phase 2]
Phase 2 trial evaluating bevacizumab with radiation therapy in soft tissue sarcomas completed, with results posted in 2017.